GlassScriptPhysician profile
Ibrahim H Sidiqi
NPI 1649470071
$16,196.59
in general payments reported to CMS, 2019-2025
38 companies · $3,619 in 2025
The $3,619 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,156 · 2020: $1,298 · 2021: $1,276 · 2022: $1,414 · 2023: $2,726 · 2024: $1,709 · 2025: $3,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,294 · Travel and Lodging: $1,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,293.55 |
| Travel and Lodging | $1,759.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,707.99 | 2019-2025 | Perclose Proglide, Supera, Esprit |
| Boston Scientific Corporation | $757.50 | 2019-2025 | Avvigo Guidance System, Rotapro, Varithena Administration Pack |
| Amgen INC. | $693.64 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $657.48 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $503.55 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $493.33 | 2019-2025 | |
| Inari Medical, INC. | $456.69 | 2021-2022 | |
| Abiomed | $448.79 | 2021-2025 | Impella |
| Medtronic, INC. | $409.58 | 2022-2023 | Corevalve Evolut R, Endurant Iis, In.Pact Admiral |
| Merck Sharp & Dohme LLC | $349.55 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $256.12 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $254.28 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $229.24 | 2020-2025 | Eliquis, Camzyos |
| Angiodynamics, INC. | $195.21 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Kestra Medical Technology Services, INC. | $178.85 | 2022-2024 | Assure Wcd |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $167.07 | 2021-2025 | |
| Penumbra, INC. | $167.01 | 2023 | Indigo System |
| Tactile Systems Technology INC | $159.26 | 2021-2022 | |
| Cardiovascular Systems INC. | $140.12 | 2019-2022 | |
| Heartflow, INC. | $139.82 | 2024 | |
| Atricure, INC. | $122.83 | 2023-2024 | |
| Scpharmaceuticals INC. | $89.82 | 2023-2025 | |
| Novo Nordisk INC | $85.52 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Biotronik INC. | $83.62 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.75 | 2021-2024 | Jardiance |
| Esperion Therapeutics, INC. | $66.80 | 2020-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $58.87 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $42.08 | 2023 | Opsumit, Uptravi |
| Philips North America LLC | $38.46 | 2024 | (Ck4) Mcot, (Cm9) Amb Mon & Diag Und |
| Inspire Medical Systems, INC. | $28.77 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $24.28 | 2022 | |
| Reflow Medical INC | $20.33 | 2025 | |
| Cvrx, INC. | $20.16 | 2024 | Barostim Neo System |
| Cook Medical LLC | $19.67 | 2023 | Zilver Ptx |
| Sanofi-Aventis U.S. LLC | $18.66 | 2023 | |
| Csl Behring | $15.90 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Thrombolex, INC. | $9.54 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Sidiqi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.